Subsequently, the authors identified a new SIRT1 inhibitor, MHY2245, which induces autophagy and inhibits energy metabolism in human ovarian cancer cells through the PKM2/mTOR pathway, providing new insights into the treatment of ovarian cancer. This evidence concerns the gene SIRT1 and ovarian carcinoma.